Zhejiang Orient Gene Biotech Co Ltd
688298
Company Profile
Business description
Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.
Contact
3787 East Section of Yangguang Avenue, Dipu Street
Anji County
Zhejiang Province
Huzhou313300
CHNT: +86 5725300267
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
2,231
Stocks News & Analysis
stocks
10 best US blue-chip stocks to buy for the long term
The stocks of these high-quality companies with large market capitalisations look undervalued today.
stocks
What next for Tesla as 2024 deliveries disappoint?
Tesla shares started the year on a sour note. We think they continue to price in ambitious growth going forward.
stocks
Best and worst performing ASX sectors of 2024
Exploring the ASX sectors that moved the market this year.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,516.50 | 4.60 | 0.05% |
| CAC 40 | 7,312.89 | 30.67 | 0.42% |
| DAX 40 | 19,966.44 | 60.36 | 0.30% |
| Dow JONES (US) | 42,732.13 | 339.86 | 0.80% |
| FTSE 100 | 8,206.74 | 17.24 | -0.21% |
| HKSE | 19,688.29 | 71.98 | -0.36% |
| NASDAQ | 19,621.68 | 340.88 | 1.77% |
| Nikkei 225 | 39,307.05 | 587.49 | -1.47% |
| NZX 50 Index | 13,072.93 | 5.10 | 0.04% |
| S&P 500 | 5,942.47 | 73.92 | 1.26% |
| S&P/ASX 200 | 8,257.40 | 6.90 | 0.08% |
| SSE Composite Index | 3,206.92 | 4.51 | -0.14% |